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ABSTRACT  In this article, proteoglycans from embryonic chick leg muscle  are quantitatively 
and  qualitatively  compared  with  day 8  high  density cell culture cartilage  proteoglycans  by 
electron microscopy of proteoglycan-cytochrome c monolayers. The visualized proteoglycan 
profiles  were  separated  into four categories  according to shape,  size, and complexity.  The 
two major categories  were further characterized by lengths  of core proteins, lengths  of side 
projections, and distance between side projections. Two large proteoglycans are identifiable 
in spread  leg muscle preparations.  One group  has a core protein (mean  length of 205  nm) 
from  which extend long thin side  projections that we interpret to be groups  of chondroitin 
sulfate  glycosaminoglycans  with  a  mean  length  of  79  nm.  This  large  chondroitin  sulfate 
proteoglycan is the only type found in muscle  cultures as determined both biochemically in 
the past and  now  by electron  microscopy  and  is  referred  to as muscle  proteoglycan.  The 
second large  proteoglycan  has a mean  core protein  length of 250 nm and side  projections 
that  are  visibly  shorter  (mean  length  of  38  nm)  and  thicker  than  those  of  the  muscle 
proteoglycan. This group is referred to as the mesenchymal proteoglycan since its biosynthetic 
origin  is still  uncertain. We compare these two profiles with the chick cartilage  chondroitin 
sulfate proteoglycan that has a mean core protein length of 202 nm and side projections with 
a  mean  length  of  50  nm.  The  data  presented  here  substantiate  the  earlier  biochemical 
characterization  of  these  noncartilage  proteoglycans  and  establish  the  unique  structural 
features of the muscle proteoglycan as compared with the similar  profiles  of the cartilage and 
mesenchymal proteoglycans. 
The Kleinschmidt cytochrome c monolayer spreading tech- 
nique (20, 32, 33) has been used to visualize and characterize 
proteoglycans. These studies have concentrated on cartilage 
(2, 4-6, 25, 28,  32-34) or cartilage tumor proteoglycans (3, 
17) and have reported on the size and complexity of  aggregates 
(3,  4,  6,  17,  32,  33),  changes in proteoglycans with age or 
anatomical location (2,  5, 25, 28),  and differences between 
organisms (4).  In this context, this laboratory has reported 
details of transmission electron microscope studies and bio- 
chemical characterization of day 8 high density chick limb 
bud culture chondrocyte proteoglycans (28). The day 8 chick 
limb bud chondrocyte proteoglycan has a  molecular weight 
of-2  x  106 with chondroitin sulfate chains of ~20,000 mol 
wt,  which  contain  67%  6-sulfated  chondroitin  sulfate.  Al- 
though cartilage and chondrosarcoma proteoglycans have re- 
ceived substantial attention, proteoglycans from several tissue 
sources have been characterized biochemically (1, 11,  12, 14, 
15, 18,  19, 22, 23, 27, 29, 31, 35-37). 
We recently biochemicaUy characterized newly synthesized 
chick cartilage and muscle proteoglycans isolated from em- 
bryos (12,  14) as a means of comparing their structure with 
that of the proteoglycans synthesized in cell cultures (11). In 
the study of in vivo proteoglycans synthesized in leg muscle, 
three distinct classes of proteoglycans were identified (11,  12). 
By Sepharose CL-2B chromatography of D1  fractions, both 
large (Kay =  0.14-0.23) and small (Kav= 0.77-0.81) proteo- 
glycans were found. The large proteoglycans could be further 
resolved upon analysis of the glycosaminoglycans by Sepha- 
rose CL-6B chromatography which revealed the presence of 
two classes  of chondroitin sulfate whose parent  molecules 
were referred to as muscle proteoglycan A and muscle proteo- 
glycan B (12).  From the data presented here and elsewhere, 
we now can state that the A-type proteoglycan is synthesized 
by skeletal muscle cells, and it is hereafter referred to simply 
as muscle proteoglycan. The origin of  the B-type proteoglycan 
is still not known and we hereafter refer to it as mesenchymal 
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enchymal origin.  Muscle cells,  fibroblasts,  satellite cells,  or 
other  connective  tissue  cells  are,  therefore,  not  excluded. 
These assignments can be made because the three classes  of 
proteoglycans have distinctive spreading characteristics  and 
morphologies as viewed in the electron microscope and re- 
ported here. 
The mesenchymal proteoglycan is similar to that of carti- 
lage proteoglycan in a number of biochemically determined 
structural  features,  whereas the muscle proteoglycan differs 
significantly  in  several  parameters  (Table  I).  The  average 
hydrodynamic size of the monomers, determined by Sepha- 
rose CL-2B chromatography, is much larger for the muscle 
proteoglycan relative to cartilage and mesenchymal proteogly- 
cans, which are similar to each other in monomer size. The 
chondroitin sulfate  chains  are  also  similar  in  size  for the 
cartilage  and mesenchymal  proteoglycans and substantially 
smaller than those of the muscle proteoglycan. It is important 
that a major difference is found in the 6-sulfated chondroitin 
sulfate,  which is unusually high for the muscle proteoglycan, 
90%  as  compared  with  66  and  60%  for the  cartilage  and 
mesenchymal proteoglycans, respectively. 
To characterize more fully the proteoglycans synthesized in 
chick muscle tissue in situ and substantiate the biochemical 
studies, the visual technique of proteoglycan-cytochrome c 
monolayer spreading and transmission electron microscopy 
has  been  employed.  The  usefulness  of proteoglycan-cyto- 
chrome c spreading of macromolecules has been amply dem- 
onstrated with cartilage  proteogiycans in the work of Rosen- 
berg et al. (32, 33) and Buckwalter et al. (3-6) among others. 
One major advantage of this technique is the ability to eval- 
uate individual molecules,  both aggregates  and monomers. 
Although numerous individual profiles must be examined to 
determine  average  parameters  for  a  large  population,  the 
technique  allows  quantitative  comparison  of  populations 
from different developmental stages (5), different tissues (2), 
or, as reported here, subpopulations within one tissue. 
The  study reported here  involves both a  qualitative and 
quantitative aspect, because at least three proteoglycan types 
have been described biochemically for in ovo muscle tissue 
(12).  Since  the  technique  of  proteoglycan-cytochrome  c 
spreading involves the evaluation of molecules on an individ- 
ual basis,  it is relatively easy to separate  the biochemically 
characterized  types  by  their  morphological  appearance  in 
monolayer spreads. Moreover, the technique ofproteoglycan- 
cytochrome  c  spreading,  which  has  been  successfully  and 
valuably applied to the examination of cartilage proteoglycans 
(2,  5,  25,  35),  is  extended  into  the  study  of noncartilage 
proteoglycans, an area  in which only a  modest  application 
has been made (26, 36). 
MATERIALS  AND  METHODS 
Isolation of Proteoglycans:  The details of isolation and purification 
procedures  for  the  proteoglycans  used  in  this  study  have  been  presented 
elsewhere (11, 12,  16,  21). Muscle tissue proteoglycans were isolated either 
from culture  material  or from whole embryos. The cultures consisted of day 
11 chick myoblasts prepared as done previously (7) and maintained  until after 
fusion of myoblasts into myotubes, day 3. The leg muscle was dissected from 
embryos of the desired age. The source of cartilage proteoglycans was day 8 
high density cultures of chick limb bud mesenchymal cells in which most of 
the cells are chondrocytes that synthesize proteoglycans whose structure closely 
resembles those  of animal  hyaline cartilage (9,  16,  21,  28). In all  cases, the 
proteoglycans were extracted with 4 M gnanidinium  chloride containing  pro- 
tease inhibitors. The density of the clarified extracts was adjusted with CsCI to 
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TABLE  I 
Biochemical  Features of the Proteoglycans from Cartilage and 
Muscle 
Mesen- 
Cartilage  Muscle  chymal 
Monomer 
K~, Sepharose CL-2B  0.25  0.1  0.2 
Estimated molecular weight  2x  106  4x  106  2.5x  106 
Chondroitin sulfate 
Kay, Sepharose CL-6B  0.50  0.26  0.47 
Estimated molecular weight  20,000  70,000  24,000 
CS chains/monomer  80-100  40-60  80 
6-Isomer/total chondroitin  66%  90%  60% 
sulfate 
Keratan sulfate 
Kay, P-30  0.19 
Estimated molecular weight  7,000 
KS chains/monomer  20-30  0  0 
Oligosaccharides 
O-linked/monomer  90-120  600*  ND 
N-linked/monomer  25-35  40*  ND 
Aggregability with hyaluronate  +  +  ND 
Data were taken from  References 8, 9,  11,  12, 14,  16, and 21  and from 
work in progress.  Cartilage proteoglycan data are for the molecules synthe- 
sized by chondrocytes in day 8 high density cultures of stage 24 chick limb 
mesenchymal cells. Skeletal  muscle proteoglycan data are for the molecules 
synthesized by myotubes in  day  3 leg muscle cultures, although  those 
parameters that have been examined with in ovo leg muscle proteoglycans 
are the same as those of the in vitro molecules. Data for  mesenchymal 
proteoglycan are from in ovo leg muscle. ND, not determined. 
* 15 O-linked and 1 N-linked oligosaccharide per chondroitin sulfate chain. 
1.50 g/ml, and the extracts were centrifuged to equilibrium  in a Beckman SW 
50.1 or 50 Ti rotor (Beckman Instruments,  Inc., Palo Alto, CA) at 35,000 rpm 
and  10*C for 44-46  h. The gradients were fractionated  into quarters  with a 
Beckman tube slicer and the fractions were dialyzed and lyophilized. For the 
studies reported here, we analyzed only the high density proteoglycans recovered 
in the DI fraction (24) which had a density of>l.60 g/ml. 
Morphological  Examination of Proteoglycans:  Lyophilized 
samples of purified proteoglycans were dissolved and stored overnight at 4"C 
in  0.5  M  sodium  acetate,  pH  7,  at  a  concentration  of ~100  ug/ml.  The 
proteoglycan solution was diluted  1:10 with  1 M ammonium acetate of which 
75  #1  was  mixed  with  20  ~1  of a  solution  containing  cytochrome  c  at  a 
concentration  of 0.5  mg/ml in  0.01 M  Tris(hydroxymethyl)aminomethane, 
0.001 M ethylenediaminetetraacetic  acid, pH 8.5. The resulting solution  was 
placed on a wet glass slide and allowed to spread over a hypophase of 0.3 M 
ammonium acetate, pH 5. The resulting monolayer was picked upon on freshly 
carbon-coated nitrocellulose films and stained in 0.2% (wt/vol) uranyl acetate 
in 90% ethanol for 1-2 rain then rinsed in 90% ethanol. Some grids were also 
rotary  shadowed  with  platinum-palladium  which  was  wrapped  around  a 
pointed  tungsten  filament and placed 8 cm from and  10" above the rotating 
grids. 
Grids  were  examined  and  micrographs  were  taken  with  a  JEOL  100S 
transmission  electron  microscope operating  at 60 kV. Nonoverlapping  fields 
were recorded  on  film  at  a  magnification  of 26,300  and  photographically 
enlarged to x 72,000 for tracing onto clear acetate. All profiles that could be 
accurately traced were included. Acetate sheet tracings were machine copied to 
white paper and individually cut out. The individual profiles of proteoglycans 
were categorized according to size, shape, and complexity to derive the collage 
figures. 
For quantitative analysis, electron microscope images were photographically 
enlarged by 128,000. Magnifications were calibrated by means of a diffraction 
grating. Proteoglycans corresponding to specific categories (1Ii and IV of  muscle 
and 11I of  cartilage) were traced with an acoustical digitizing pen. Measurements 
recorded included length of  core protein, length of  side projections (correspond- 
ing to groups of glycosaminoglycans), and distance between side projections. 
Statistical analysis was performed on a PDP-I 1/34 computer (Digital Equip- 
ment Corp., Maynard, MA). FIGURE  I  Sepharose CL-2B profiles with corresponding cytochrome c (cyto. c) spread molecules.  (A) Day 8 high density culture 
chondrocyte proteoglycans.  The major molecule in the spread  preparation is a larger proteoglycan with short side  projections. 
(B) Day 11  embryonic leg muscle  proteoglycans (PG). The two major proteoglycans  are both relatively large, but one has long, 
thin side  projections  (arrow),  and  the  second  has short,  thick side  projections  or  swellings (double arrowheads).  (C)  Day  3 
myogenic culture proteoglycans.  Only one type of large proteoglycan (arrowheads)  is present;  it has long thin side  projections. 
Note that the column profiles represent only newly synthesized molecules and comparable results have been reported previously 
(11, 12, 21). Bar, 250 nm. Vo, void volume; Vt, total volume. 
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Qualitative Characterization 
Fig.  1 shows  the  Sepharose CL-2B elution profiles and 
corresponding transmission  electron  micrographs  of cyto- 
chrome c spread monolayers of the three proteoglycan sam- 
pies examined in this article. These three proteoglycans are 
all  chondroitin  sulfate  proteoglycans.  Day  8  high  density 
culture cartilage proteoglycans (Fig.  1  A) have been detailed 
elsewhere (21, 28) and represent a standard with which other 
chick proteoglycans can be compared. The major peak has a 
K=v of 0.25 and the electron micrograph presents a random 
population of largely uniform images whose side projections 
are short or collapsed and appear as bumps on both sides of 
the long axis (the core protein). Leg muscle proteoglycans 
from day  11  embryos (Fig.  1  B) show a different Sepharose 
CL-2B profile (11,  12, 14) and present two clearly identifiable 
images of large proteoglycans. One image is similar to those 
observed with cartilage proteoglycans with short or collapsed 
side projections (double arrowheads), and the other has no- 
ticeably extended side projections that are perceptibly thinner 
and arranged along the axis or core protein (single  arrow- 
heads). 
In spreads of molecules isolated and purified from muscle 
cultures, only the  images  with  long,  thin,  well-spread side 
projections are observed (Fig.  1 C, arrows).  In no case is the 
other type of large proteoglycan observed in the muscle cul- 
ture preparations. Biochemical analysis of the proteoglycans 
I  13%  It  6%  Ill  20% 
,#.*.  ~,  ,..~.  t*,~ 
i,  *  :"  Ii  'i"  ,.,ll,  /,~  ~%,.~,P 
•  ,,  p  •  ,~e...,--¢  "'7  ..~K.  I  I 
•  l)"  *J"~  i~*,.~  .llli.ll  r 
"  •  "%  "i  ,,.~  il~l  IIi  •  II 
•  ~,~.,  "~  "~  i,',.  "t*t  e 
•  •  iI  .~,.,~..,.~  ~..t~ li.~l  ! 
• 
•  "l  "i'l  I,-*"  V 
•  •  ~  '~  ,,,..- 
I 
•  •  l,i*  ll~*  *r,l~r ~*" 
IV  61% 
250nm 
,,4,  "1  •  .,~  ~  ~  ,__  ~  /i  .._',i:..  ~  ~-z-  .,,.._-,_,--  .,,.'~-~.li,tJ' 
.....  ,-,...i,  ,.,__ 
i~'  ~  -  -#il," "l"  ~  ~  ~  "  --  ~"  ~"  -"i- 
V"  <"  • 
FiGure  2  Collage of 386 molecular profiles of day 11 leg muscle proteoglycans from the D1 fraction of a cesium chloride density 
gradient. Tracings were made from cytochrome c spread preparations and categorized according to size, shape, and complexity. 
Criteria for the various categories are explained in the text. Bar, 250 nm. 
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large  chondroitin  sulfate  muscle  proteoglycan is  produced 
with the complete absence of synthesis of the mesenchymal 
proteoglycan (l l,  12,  14). Based on these qualitative obser- 
vations and the quantitative measurements provided below, 
we are confident in  assigning  the cells of origin of the two 
large proteoglycan images seen in the spreads of in vivo leg 
muscle molecules. Because of the structural similarities be- 
tween cartilage proteoglycan and mesenchymal proteoglycan 
(the chondroitin sulfate chains of similar size and sulfation 
pattern; see Table l), we feel that the more condensed images 
seen in  the spreads of day  l l  embryo leg muscle  material, 
which resemble the major images observed in cartilage pro- 
teoglycan spreads, represent molecules of mesenchymal pro- 
teoglycan. The fact that  only one morphology, that of the 
highly spread molecules, is seen in preparations from muscle 
cultures argues against the possibility of artifacts that result in 
"collapsed" and "expanded" images in cytochrome c spreads 
of in vivo day 11  leg muscle proteoglycans and substantiates 
our  identification  of the  highly  spread  images  as  muscle 
proteoglycans. 
Proteoglycans isolated from  leg  muscle  of day  11  chick 
embryos (D1  molecules) were prepared on carbon films and 
morphologically categorized  as  outlined  in  Materials  and 
Methods. A total of 386 monomer profiles were recorded and 
placed into one of four categories. Although any given profile 
may be placed into one of several areas of the collage,  the 
arrangement in  Fig.  2  is a  fair representation of the major 
types and  proportions of proteoglycans present within  the 
sample.  The arrangement is designed to give order to the 
random  appearance  of proteoglycan molecules as  seen by 
electron microscopy. We evaluated all recognizable proteogly- 
can profiles so as not to bias the results toward a particular 
type  of profile.  Self-aggregated  profiles,  although  grouped 
together in the collage (upper right portion of Fig.  2),  were 
placed in their respective categories as monomers to derive 
the  stated  percentages.  This ordering allows  a  quantitative 
view of the distribution of all macromolecules present in the 
sample. 
Category  I,  which  represents  13%  of the  total,  can  be 
described as comprising relatively small profiles that range 
from 20 to 110 nm with no apparent axis (Fig. 2). Category 
II also comprises relatively small units (from 60 to 150 nm) 
but an axis is discernible, although side projections are absent 
or ill-defined; this group comprises 6% of the total. Category 
III, which represents 20% of the sample, is characterized by 
profiles with a  long axis-to-diameter ratio of at least 3; the 
long axes range from  150 to 300 nm and side projections, if 
present, are short or,  more often, visualized as swellings  or 
bumps along the long axis. The average length and standard 
deviation of these profiles as measured from the collage are 
247 and 48 nm, respectively. Category IV, comprising 6 t % 
of the total, has been put in a profile gradient from relatively 
simple  profiles that  are  short  with  few side  projections to 
complex profiles with relatively long axes and numerous side 
arms.  As  a  whole, this  group has  long,  well-extended side 
projections and the molecules, as measured from the collage, 
range in length from 89 to 658 rim, while the mean length is 
282 nm with a standard deviation of 104 nm. 
The  collage  reveals that  the  variability in  the  length  of 
molecules in category lII is small as compared with that of 
category IV. Micrographs illustrating the differences seen in 
the degree of spreading within the major categories, lII and 
IV, exemplify this variability (Fig.  3). Category IlI is repre- 
sented by a  molecule 250 nm  long with collapsed or short 
side projections (Fig. 2, A-C), and category IV is characterized 
by molecules that  vary greatly in  length but,  regardless  of 
length, exhibit exceptionally long, thin side projections (Fig. 
3, D-F). These category IV molecules are relatively insensitive 
to the properties of  the supporting substrate, in that even with 
little or  no carbon  present  on the  nitrocellulose films,  the 
molecules with  long,  thin  side  projections  can  be  deafly 
visualized (data not shown), whereas category III molecules 
exhibit spread side  projections only under optimum condi- 
FIGURE  3  Cytochrome c  spread  molecules of day  1  i  leg muscle  proteoglycan monomers  (rom  the  D1  fraction  of a  cesium 
chloride density gradient. In A-C are molecules that illustrate the various degrees of side-projection spreading of the mesenchymal 
proteoglycan (category III molecules of Fig. 2). In D-F are molecules that represent muscle proteoglycan (category IV of Fig. 2). 
Bar, 250 nrn. x  73,600. 
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FIGURE  4  Collage of 634 molecular profiles of day 8 high density culture chondrocyte proteoglycans from the D1  fraction of a 
cesium chloride density gradient. Tracings were made from a cytochrome c preparation and categorized according to size, shape, 
and complexity. Bar, 250 nm. 
tions and, at all times, the side projections are thicker and 
shorter than those of the category IV molecules. 
Although the above categories may be artificial groupings 
of  molecules, they permit further analyses of  spread molecules 
as groups rather than a heterogeneous and random mixture 
of images. Categories III and IV, which represent ~80%  of 
the  profiles  present,  were  further  analyzed.  Although  the 
actual decision to relate these two categories to groups known 
by biochemical characteristics was not made until all mor- 
phological analyses were completed, category III molecules 
will be described as mesenchymal proteoglycans, category IV 
molecules  as  muscle  proteoglycans.  These  morphological 
types correspond to the classification of the two major proteo- 
glycans biochemically described in developing muscle (l 2). 
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Cartilage  Proteoglycans  as a Standard 
Detailed biochemical and electron microscopic studies of 
chick limb bud chondrocyte culture proteoglycans have been 
published (16,  21, 28).  For comparison and because we con- 
sider these molecules to be standards, we undertook an elec- 
tron-microscopic analysis similar to that described above for 
the muscle proteoglycan. A total of 634 profiles were recorded 
which could be grouped into three categories (Fig. 4). Mono- 
mers of self-aggregated profiles (upper fight portion of Fig. 4) 
were separately traced and placed in their respective categories 
as  monomers, which  increased  the  number of categorized 
monomers to  683.  Categories  I  and  II correspond  to  the 
comparable groups for leg muscle (Fig. 2). The lengths range from  II to  118  nm for category I, which represents  10% of 
the total population, and from 58 to  190 nm for category II, 
which represents 13% of the total. Category III, which repre- 
sents 77% of this sample, is characterized by a long axis-to- 
diameter ratio of at least 3. The long axes range in size from 
73 to 391 nm and side projections are visualized as a gradient 
from  mere  swellings  along  the  long  axis  to  extended  side 
projections.  The  average length  and  standard  deviation  of 
these profiles as measured from the collage are 206 and  57 
rim, respectively. Category III can be characterized as a gra- 
dient from relatively simple profiles that are short with few 
side projections to complex profiles of  long axis and numerous 
side projections. 
Examples at  higher  magnification from this cartilage D I 
preparation representative of molecules grouped in category 
III are shown in Fig.  5. We believe that all of the profiles of 
category III represent the same proteoglycan type, but due to 
variability in the degree of spreading of the side projections 
(assumed to be groups of chondroitin sulfate glycosaminogly- 
cans), a gradient exists from dense unextended molecules (Fig. 
5A) through less dense profiles with maximally extended side 
projections (Fig.  5D),  although  the  latter are,  nevertheless, 
clearly distinct from the leg muscle proteoglycan category IV 
images  described  above  (compare  Fig.  5D  with  3F.)  The 
quantitative data presented below were obtained from such 
micrograph profiles rather than collage profiles. Due to diffi- 
culty in accurately measuring side projection lengths of many 
of the category III profiles, all data were collected from the 
most spread and clearly defined profiles as represented in Fig. 
5D. 
Quantitative Characterization 
Profiles of day  11  leg muscle molecules representing mes- 
enchymal and  muscle proteoglycans (categories III and IV, 
respectively) were selected for detailed analysis. Micrographs 
were enlarged to give final magnifications of 100,000-125,000 
and the molecular profiles were traced with a digitizing pen 
as described in  Materials and Methods.  Since mesenchymal 
proteoglycan molecules exhibit extended side projections only 
rarely,  molecular profiles were  selected that  had  such  side 
projections so that they could be measured with reasonable 
accuracy. Therefore,  the  resulting data  represent the  maxi- 
mally extended side projections of this group (Fig.  3, B and 
C),  whereas  measurements of axis length  were determined 
separately for molecules without  extended  side  projections 
(Fig.  3A) as well  as for molecules with extended side arms. 
FIGURE 5  Cytochrome c spread  molecules of day 8  high density 
culture chondrocyte proteoglycan molecules.  A-D represent  mol- 
ecules of category III (Fig. 4) and illustrate the various degrees  of 
side-projection  extension found  in this group. All histogram  data 
(Figs. 6-8) were collected from  molecules of the type seen  in D. 
Bar, 250 rim.  x  70,000. 
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FIGURE 6  Histograms of core protein length. Vertical bars indicate 
mean value. (,4) Day 11  leg muscle,  muscle proteoglycan. (B) Day 
11  leg muscle,  mesenchymal proteoglycan. (C) Day 8 high density 
cell culture, cartilage proteog}ycan. 
The resulting mean and standard deviations for these length 
measurements are the same (250 +  48; 258 ___ 44 nm). In a 
comparison of molecules of different types, we selected the 
category III molecules with more extended side projections 
for analysis of the lengths of the axes (assumed to be equiva- 
lent to core protein  length),  lengths  of the  side projections 
(assumed to be groups of glycosaminoglycan chains), and the 
distance between the side projections. In this analysis of the 
muscle proteoglycan molecules (category IV), the difficulty 
was in obtaining accurate determinations of the core protein 
component of some molecular profiles, since the diameter of 
the  side projections was often the  same as that of the  core 
protein. Data for the muscle proteoglycan were obtained from 
molecular profiles in which the core protein could be clearly 
discriminated from the side projections, regardless of the core 
protein length. 
The results of such analysis are shown as histograms (Figs. 
6-8).  The  axis  (core  protein)  of the  muscle  proteoglycan 
monomers, measured  from 411  images,  varies widely (Fig. 
6A). The mean length was determined to be 205  nm with a 
standard deviation of 82. The minimum and maximum axis 
lengths  were 25  and  525  nm,  respectively. Lengths  of 257 
molecules of the  mesenchymal  proteoglycan were likewise 
determined (Fig. 6B). Although the lengths range from a low 
of~100 nm to a high of 425 nm, 80% were between 200 and 
300 nm, with an average length  of 250  nm and a  standard 
deviation of 48. The shapes of the two histograms reflect the 
contrast  in  variability  of the  core  protein  lengths  in  the 
category III and category IV molecules. (Compare Fig.  6, A 
with B.) For comparative purposes, the core protein lengths 
of day 8 high density chick limb bud culture cartilage proteo- 
glycan has a  mean value of 202 nm (Fig.  6 C), very close to 
that of the muscle proteoglycan. However, the shapes of the 
two histograms differ in that the cartilage culture material has 
a much smaller variability with a standard deviation of 47. 
The lengths of core proteins of chick cartilage proteoglycan 
have been reported by Kimura et al. (28). Their measurements 
made from aggregated and reaggregated monomers are con- 
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Day  11  leg muscle, muscle  proteoglycan.  (B) Day 11  leg muscle, 
mesenchymal proteoglycan. (C) Day 8 high density cartilage culture, 
cartilage proteoglycan.  See text for description. 
sistently longer than those reported here. A partial explanation 
could be that proteoglycans in aggregate form often exhibit a 
hyaluronic acid binding region that attaches the chondroitin 
sulfate-rich region to hyaluronic acid (4). When monomeric 
proteoglycans are identically spread for electron microscopy, 
the hyaluronic acid binding region is less clearly visible or has 
folded back on itself, making the molecule appear shorter. To 
determine if the aggregated versus dissociated conditions of 
proteoglycans could explain the differences in size, we mea- 
sured  the  core  protein  lengths  of day  8  culture  cartilage 
proteoglycan aggregates by the means used in this study. The 
lengths of proteoglycan monomers measured in such aggre- 
gates were only slightly longer than those measured as disso- 
ciated monomers (225 _+ 69 vs. 202 +_ 48; data not shown). 
We can offer no obvious explanation for the discrepancy in 
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the core protein  lengths  measured in  this analysis and the 
previous one. Inclusion of catalase crystals on the carbon film 
of the grids used for spreading would provide a more accurate 
determination of the magnification, but such a method was 
not employed in the previous study of these proteoglycans in 
which the magnification was calibrated in a manner similar 
to that used here (28). 
The muscle proteoglycan has a mean side projection length 
of 79 nm with a standard deviation of 27,  and the shape of 
the histogram is symmetrical around the mean (Fig. 7A). The 
mean side projection length for the mesenchymal proteogly- 
can is 38 nm with a standard deviation of 16, and the shape 
of the histogram is somewhat skewed to the lower values (Fig. 
7B).  Cartilage  proteoglycans have  a  mean  side  projection 
length of 50  nm  with  a  standard  deviation  of 26,  and  the 
shape of the histogram is skewed heavily toward the  lower 
values. The nonsymmetrical shape of the histograms around 
the  means is an  indication  of the  number of partially col- 
lapsed, or not fully expanded, side projections in the latter 
two groups. The biochemical characteristics of the glycosami- 
noglycans in  the  mesenchymal  and  cartilage  proteoglycan 
may be responsible for the shorter and thicker appearance of 
the side projections when spread by the cytochrome c tech- 
nique. 
Fig.  8  illustrates  a  similarity  of the  three  proteoglycans 
under study. The distance between side projections was deter- 
mined irrespective of the side of the core protein from which 
projections extended. Therefore, two adjacent projections ex- 
tending from opposite sides of the axis represent a distance 
between side projections of zero. Since the frequency of this 
situation is large, most values are between 0 and 10 nm in all 
three cases. The second most common spacing, although not 
always visually evident in a random population of molecules, 
is apparent when the data are plotted with appropriately sized 
groupings. The peak of this distance falls between 25 and 30 
nm in all three histograms, with few side projections >60 nm 
apart.  Since  the  side  projections  are  thought  to  represent 
groups of chondroitin  sulfate chains,  this spacing of 25-30 
nm may indicate the distance between the groups of chon- 
droitin  sulfate  chains  that  are  close  enough  to  condense 
together to form a single side projection. 
DISCUSSION 
Since Rosenberg et al. (32,  33) first applied the technique of 
cytochrome c spreading of macromolecules to bovine nasal 
septum proteoglycans, a number of microscopic studies have 
been done on cartilage proteoglycans from a variety of sources 
(2, 4,  5, 20,  25,  28,  34).  Recent work in this laboratory has 
dealt with the involvement of extracellular matrix molecules 
in  the  embryonic development of chick with the  focus on 
changes in proteoglycans during cartilage, muscle, and bone 
development (8-14,  21,  30).  This report extends those bio- 
chemical and morphological analyses and attempts to char- 
acterize the unique  muscle proteoglycan by visual observa- 
tions and correlate these findings with known biochemical 
characteristics. As a basis of comparison, chick cartilage pro- 
teoglycans from culture were further characterized as a stand- 
ard.  In this regard, only D I  molecules were analyzed.  The 
differences  in  morphology of the  two  large  proteoglycans 
isolated from the leg muscle of day I l embryos are sufficient 
to  permit  grouping  of individual  molecules  into  separate 
categories based on visual interpretation of qualitative char- acteristics. The categories could be further analyzed quanti- 
tatively to determine variations between the different mole- 
cules. 
Viewing of spread proteoglycans in the D1  fraction pre- 
pared from chick embryonic leg muscle affirms the presence 
of a unique proteoglycan that has very long side projections. 
To assess quantitatively these and other molecules, all recog- 
nizable spread molecules were grouped into simple categories 
based on size, shape, and complexity. There is no definitive 
means of determining from available data the relationship of 
categories I and II to what is known about the proteoglycans 
by biochemical analysis.  They could represent fragments of 
larger proteoglycans or they could be images of the dermatan 
sulfate  and  heparan  sulfate  fibroblastic  proteoglycans  de- 
scribed biochemically as small units with perhaps only one or 
two glycosaminoglycans (12). On the other hand, categories 
III and IV, which make up most of the embryonic leg muscle 
proteoglycans found in the DI  fraction, can be directly cor- 
related with the biochemical characteristics. We identify the 
category IV molecules as muscle proteoglycan because my- 
ogenic cells in culture synthesize proteoglycans that have the 
category IV morphology of long side projections extending 
from a core length of ~250 rim. The other image in day 1  l 
embryo leg  muscle proteoglycan spreads (i.e.,  category |II) 
resembles that observed with  cartilage proteoglycan whose 
side projections are  usually not extended even though the 
core length is also in the 200 to 250 nm range, and these 
molecules are identified as mesenchymal proteoglycan. 
Wight and Hascall (36) characterized a large proteoglycan 
isolated from arterial smooth muscle. Superficially, the skel- 
etal muscle proteoglycan described in this report resembles 
the smooth muscle proteoglycan as visualized by molecular 
spreading  techniques.  The  side  projection  lengths  on  the 
smooth muscle proteoglycan average 70-75 as compared with 
79 nm for the skeletal muscle proteoglycan. The core protein 
length of the smooth muscle proteoglycan is shorter, 140 vs. 
205 nm. These differences are probably reflected in the hy- 
drodynamic sizes of the two molecules. The skeletal muscle 
proteoglycan has a Sepharose CL-2B Kay of 0.1  (Table I) as 
compared with 0.31  for the smooth muscle proteoglycan. In 
addition, the estimated average molecular weight of  the chon- 
droitin sulfate present in the skeletal muscle proteoglycan is 
substantially larger, 70,000 vs. 40,000. Although the two large 
muscle  proteoglycans are  not  identical  in  structure,  both 
contain exceptionally long glycosaminoglycan chains that are 
easily discernable by electron microscopy from those of car- 
tilage proteoglycan. 
It must be stated that the biochemical analyses of proteo- 
glycan monomers and glycosaminoglycans are derived strictly 
from [aSS]sulfate-labeled molecules (1 l, 12, 14) and, therefore, 
represent the sulfated proteoglycans synthesized by cells over 
a restricted time frame (6 h). In contrast, the images analyzed 
by molecular spreading represent all the D1 macromolecules 
present in the tissue at the time of isolation. In the electron 
microscopic analysis,  there is a  3"1  ratio of category IV to 
category III molecules (i.e.,  muscle proteoglycan to mesen- 
chymal proteoglycan), whereas in the biochemical analysis, 
the  synthesis  of mesenchymal  proteoglycan on  day  l l  is 
considerably greater than that of muscle proteoglycan, per- 
haps as much as fourfold higher (12).  The difference in the 
relative amounts of category III and IV molecules determined 
morphologically and muscle proteoglycan and mesenchymal 
proteoglycan measured biochemically may result  from the 
fact that in the latter only newly synthesized molecules are 
analyzed and the turnover of the two classes  of molecules 
may be different. Thus, if the mesenchymal proteoglycan is 
catabolized  much  more  rapidly,  the  muscle  proteoglycan 
would be expected to accumulate in the tissue relative to the 
mesenchymal proteoglycan, in spite of its lower amount of 
synthesis, which would reconcile the biochemical and micro- 
scopic  observations.  Studies  of the  turnover of these  two 
proteoglycans are in progress. 
By visualizing molecules in  the electron microscope, we 
can identify and quantify the two large muscle proteoglycans 
that have been elucidated biochemically. Separating these two 
groups by purely biochemical means is difficult if not impos- 
sible (12).  However, as presented in this report, these mole- 
cules can be quantitatively evaluated under the electron mi- 
croscope as two completely separate groups. Electron micro- 
scopic visualization of proteoglycans can be used to compare 
resident molecules (visualized by spreading) with newly syn- 
thesized molecules (analyzed biochemically by radiolabeling). 
We have shown that synthesis of  the large proteoglycans, both 
muscle and mesenchymal, decreases in older tissues (I 2), but 
it has not been determined if either or both of these proteo- 
glycans are catabolized or reside in the tissue long after the 
cessation of their synthesis.  This can be addressed by molec- 
ular spreading techniques that examine all the proteoglycans 
present in the tissue at isolation. 
The extension of the glycosaminoglycans of the  muscle 
proteoglycan must be due to inherent characteristics of the 
molecule,  since  these  differences relative to  cartilage  and 
mesenchymal  proteoglycans were  predicted  from  the  bio- 
chemical characterization of glycosaminoglycans from each 
group. Although the molecules from the cartilage preparations 
could be grouped similarly to the muscle material, monomers 
of the category IV type of the leg muscle material are never 
observed. The fact that the muscle proteoglycan retains its 
spreading characteristics regardless of  the presence or absence 
of carbon on the grids may imply a rigidity of these glycos- 
aminoglycans that  is  not  present  in  the  mesenchymal  or 
cartilage proteoglycans. As of now, the reason for the unique 
morphologies is undetermined. It could be due to the differ- 
ences in the size or sulfation position of  their glycosaminogly- 
cans or their frequency of chondroitin sulfate chains along 
the core protein. Such possibilities  can be tested by compari- 
son of the spreading morphologies of proteoglycans of differ- 
ent structure and proteoglycans whose structures are altered 
chemically or enzymatically. We are now conducting studies 
of this type. 
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